Compare PLYM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLYM | SNN |
|---|---|---|
| Founded | 2011 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 974.8M | 13.9B |
| IPO Year | 2017 | 1999 |
| Metric | PLYM | SNN |
|---|---|---|
| Price | $21.94 | $33.69 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 4 |
| Target Price | $21.14 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 1.5M | 602.9K |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | ★ 4.38% | 2.16% |
| EPS Growth | ★ 11196.82 | 59.91 |
| EPS | ★ 2.04 | 0.56 |
| Revenue | $163,681,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $1.88 | $7.71 |
| Revenue Next Year | $9.24 | $5.23 |
| P/E Ratio | ★ $10.77 | $60.74 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | $12.70 | $23.69 |
| 52 Week High | $22.74 | $38.79 |
| Indicator | PLYM | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 56.56 |
| Support Level | $21.88 | $32.42 |
| Resistance Level | $21.92 | $34.20 |
| Average True Range (ATR) | 0.04 | 0.40 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 86.96 | 70.79 |
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.